Dr. Julio Montaner, Director of the BC Centre for Excellence in HIV/AIDS (BC-CfE), has been recognized by the Canadian Institutes of Health Research (CIHR) with the prestigious Barer-Flood Prize in Health Services.

January 11, 2016 (Vancouver, BC) The Indiana University (IU) School of Medicine and the BC Centre for Excellence in HIV/AIDS (BC-CfE) have joined forces to respond to a highly concentrated HIV epidemic driven by the injection of prescription opioids in Austin, Indiana. Austin, in Scott County, has an estimated population of 4,200 with approximately 10

In response to a letter from the Director of the BC Centre for Excellence in HIV/AIDS (BC-CfE) Dr. Julio Montaner, all federal political parties – except the Conservative government – pledged their support of a global target to end AIDS by 2030. On September 22, Dr. Julio Montaner wrote an open letter to Prime Minister Stephen Harper, which was also sent to all leaders of the Canadian federal parties, calling on the federal government to formally endorse the United Nations HIV/AIDS strategy. The 90-90-90 Target, created by UNAIDS, is based on the made in BC concept of Treatment as Prevention¨ (TasP¨) pioneered by Dr. Montaner.

HIV testing in parts of Canada remains based on”perceived risk” and could be keeping people living with the disease from discovering their status. A new study, based on the largest Canadian database of people living with HIV, finds nearly half of those surveyed started antiretroviral treatment (ART) when they had already reached an AIDS-defining illness or a weakened immune system.

Due to the introduction of modern highly active antiretroviral therapy (HAART), people living with HIV are now much less likely to develop AIDS-related cancers, which were characteristic of the epidemic in the 1980s. However, a new study published in HIV Medicine shows women living with HIV still have a higher likelihood of being diagnosed with certain cancers, when compared with the general population.

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is proud to announce its director, Dr. Julio Montaner, has been selected as a recipient of the 2015 McLaughlin Medal by the Royal Society of Canada (RSC).

A new study finds patients who start HIV combination antiretroviral treatment (cART) at high CD4 levels – when the immune system is still healthy – have higher likelihood of long-term adherence and better clinical outcomes. Published in the journal AIDS

I echo Chris´s sentiments. It has been a terrific week. Science, venue, weather, volunteers, staff, delegates and even Pope Francis; everything came together better than we ever hoped.
It has been quite a conference. Indeed, a transformational week. Much, as in Vancouver 1996, this has been a game changer for HIV. IAS 2015, with more than 6,500 delegates from all over the world, comes on the heels of three major achievements.

Vancouver, BC [July 21, 2015] – New research shows that HIV treatment for illicit drug users improves their social and socioeconomic wellbeing as well as their health.